During the past decade, Frontier Institute conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Frontier Institute" #1 sponsor was "Otsuka Pharmaceutical Development & Commercialization, Inc." with 2 trials, followed by "Assurex Health Inc." with 1 trials sponsored, "New York State Psychiatric Institute" with 1 trials sponsored, "Novartis" with 1 trials sponsored and "Novartis Pharmaceuticals" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Frontier Institute" #1 collaborator was "Duke University" with 1 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 1 trials as a collaborator, "Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator, "University of Michigan" with 1 trials as a collaborator and "University of North Carolina, Chapel Hill" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Frontier Institute" are "Schizophrenia" (3 trials), "Major Depressive Disorder" (2 trials), "Major Depressive Disorder (MDD)" (2 trials), "Agitation in Patients With Dementia of the Alzheimer's Type" (1 trials) and "Schizoaffective Disorder" (1 trials). Many other conditions were trialed in "Frontier Institute" in a lesser frequency.

Most popular intervention types in "Frontier Institute" are "Drug" (7 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "ADT" (1 trials), "AGO178" (1 trials), "AVP-786" (1 trials), "Brexpiprazole" (1 trials) and "GeneSight Psychotropic" (1 trials). Other intervention names were less common.

The vast majority of trials in "Frontier Institute" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Frontier Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Frontier Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Frontier Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".